• A case report of thrombocytopenic COVID-19 and Miller-Fisher syndrome on a concurrent chronic immune neuropathy
• A Practical Guide to Identify Patients With Multifocal Motor Neuropathy, a Treatable Immune-Mediated Neuropathy
• A rare presentation of acute-onset chronic inflammatory demyelinating polyneuropathy with the detection of anti-GM3 and anti-sulfatides antibodies: a case report
• Acute Multiple Cranial Neuropathies in Chronic Inflammatory Demyelinating Polyneuropathy: A Case Report and Scoping Review of the Literature
• Acute-onset chronic inflammatory demyelinating polyneuropathy following AstraZeneca COVID-19 vaccine: a case report
• Aggressive Acquired Demyelinating Neuropathy Caused by NF-155: Initially Treatment-Resistant
• Amyotrophic lateral sclerosis with demyelinating neurophysiology and a motor band sign
• An atypical form of chronic inflammatory demyelinating polyneuropathy presenting with initial isolated bulbar weakness
• An immuno-DOT diagnostic assay for autoimmune nodopathy
• Animal models of immune-mediated demyelinating polyneuropathies
• Anti-contactin 1 Antibody-associated Membranous Nephropathy in Chronic Inflammatory Demyelinating Polyneuropathy with Several Autoantibodies
• Anti-MAG neuropathy: historical aspects, clinical-pathological correlations, and considerations for future therapeutical trials
• Anti-neurofascin-155 antibody mediated a distinct phenotype of chronic inflammatory demyelinating polyradiculoneuropathy
• Antibodies in Autoimmune Neuropathies: What to Test, How to Test, Why to Test
• Autoantibodies Against Dihydrolipoamide S-Acetyltransferase in Immune-Mediated Neuropathies
• Autoimmune nodopathy with anti-contactin 1 antibody characterized by cerebellar dysarthria: a case report and literature review
• Axillary and musculocutaneous neuropathies
• Case Report: Chronic inflammatory demyelinating polyradiculoneuropathy rather than hemophagocytic lymphohistiocytosis-the initial phenotype of PRF1 gene mutation
• Central nervous system involvement in chronic inflammatory demyelinating polyradiculoneuropathy-MRS and DTI study
• Challenges in the Early Diagnosis and Treatment of Chronic Inflammatory Demyelinating Polyradiculoneuropathy in Adults: Current Perspectives
• Chronic Inflammatory Axonal Polyneuropathy: An Entity by Itself
• Chronic Inflammatory Demyelinating Polyneuropathy and Evaluation of the Visual Evoked Potentials: A Review of the Literature
• Chronic inflammatory demyelinating polyneuropathy and HEV antibody status: A case-control study from Lazio, Italy
• Chronic inflammatory demyelinating polyneuropathy following COVID-19 vaccination: a case report and literature review
• Chronic inflammatory demyelinating polyneuropathy with pulmonary nocardiosis: A case report
• Chronic inflammatory demyelinating polyneuropathy. A case description
• Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP)
• Chronic Inflammatory Demyelinating Polyradiculoneuropathy as a Presentation of Plasmacytoma
• Chronic inflammatory demyelinating polyradiculoneuropathy associated with neuromyelitis optica spectrum disorder: A rare case report
• Chronic Inflammatory Demyelinating Polyradiculoneuropathy with Diplopia Caused by an Alternative Coronavirus Disease 2019 Vaccine
• Chronic Inflammatory Demyelinating Polyradiculoneuropathy: Current Therapeutic Approaches and Future Outlooks
• Chronic polyradiculoneuropathy associated with pembrolizumab for bladder cancer
• CIDP Variants
• Clinical characteristics of patients with autoimmune nodopathy with anti-neurofascin155 antibodies
• Correction: Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP)
• CSF CXCL13 is elevated in patients with CIDP and may reflect higher disease activity
• Current Biomarker Strategies in Autoimmune Neuromuscular Diseases
• Cutting edge of diagnosis and treatment for chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) based on the EAN/PNS guideline 2021
• Cytokines and chemokines in patients with chronic inflammatory demyelinating polyradiculoneuropathy and multifocal motor neuropathy: A systematic review
• Diagnosing CIDP: Can we look forward by looking back?
• Diagnostic value of lower extremity ultrasonographic nerve enlargement for differentiating demyelinating Charcot-Marie-Tooth disease from chronic inflammatory demyelinating polyneuropathy
• Distinct Clinical Courses and Shortened Lifespans in Childhood-Onset DNA Polymerase Gamma Deficiency
• Do corticosteroids aggravate pure motor chronic inflammatory demyelinating polyneuropathy?
• Efficacy, safety and tolerability of rozanolixizumab in patients with chronic inflammatory demyelinating polyradiculoneuropathy: a randomised, subject-blind, investigator-blind, placebo-controlled, phase 2a trial and open-label extension study
• Efgartigimod as a novel FcRn inhibitor for autoimmune disease
• Electrodiagnostic studies and new diagnostic modalities for evaluation of peripheral nerve disorders
• Evaluating yield and utilization of ganglioside antibody testing in clinical practice
• Evaluation of diagnostic yield of the 2021 European Academy of Neurology/Peripheral Nerve Society diagnostic criteria for CIDP
• Extensive arm skin necrosis following administration of unfractionated heparin
• Genetic analyses of inflammatory polyneuropathy and chronic inflammatory demyelinating polyradiculoneuropathy identified candidate genes
• Guillain-Barré syndrome associated with Epstein-Barr virus and cytomegalovirus reactivation during treatment for chronic graft-versus-host disease after allogeneic bone marrow transplantation
• Hematopoietic stem cell transplantation (HSCT) for chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): Is it CIDP?
• High-dose pharmaceutical-grade biotin in patients with demyelinating neuropathies: a phase 2b open label, uncontrolled, pilot study
• Identification of rare variants in the FBXO38 gene of patients with chronic inflammatory demyelinating polyradiculoneuropathy
• Immunoglobulin use in neurology: a practical approach
• Impact of 2021 European Academy of Neurology/Peripheral Nerve Society diagnostic criteria on diagnosis and therapy of chronic inflammatory demyelinating polyradiculoneuropathy variants
• Intravenous immunoglobulin for chronic inflammatory demyelinating polyradiculoneuropathy
• Leprosy Presenting as Distal Acquired Demyelinating Symmetric Variant of Chronic Inflammatory Demyelinating Polyneuropathy: An Atypical Manifestation of Hansan's Disease
• Long-term follow-up of relapse and remission of CIDP in a Chinese cohort
• Low-dose rituximab treatment in a patient with anti-neurofascin-155 IgG4 autoimmune nodopathy
• Lower extremity peripheral nerve block for total knee arthroplasty in a patient with chronic inflammatory demyelinating polyneuropathy: A case report
• Management of chronic inflammatory demyelinating polyradiculoneuropathy
• Membrane Proteome-Wide Screening of Autoantibodies in CIDP Using Human Cell Microarray Technology
• Modern aspects of diagnosis and treatment of chronic inflammatory demyelinating polyneuropathy in children
• Modern Perspectives on Peripheral Neuropathology
• Musculoskeletal adverse events induced by immune checkpoint inhibitors: a large-scale pharmacovigilance study
• Myokymia in a Patient with Chronic Inflammatory Demyelinating Polyradiculoneuropathy
• Nerve enlargement differs among chronic inflammatory demyelinating polyradiculoneuropathy subtypes and multifocal motor neuropathy
• Outcome measures in pediatric chronic inflammatory demyelinating polyradiculoneuropathy
• Painless Legs and Moving Toes in Chronic Inflammatory Demyelinating Polyradiculoneuropathy
• Parkinson's disease and chronic inflammatory demyelinating polyneuropathy: Broadening the clinical spectrum of VCP mutations
• Peripheral Neuropathy and Muscle Disorders as Immune-Related Adverse Events
• Physician awareness and understanding of chronic inflammatory demyelinating polyradiculoneuropathy in Japan: a web-based study
• Prevalence, Clinical Profiles, and Prognosis of CIDP in Japanese Nationwide Survey: Analyses of 1,257 Diagnosis-Confirmed Patients
• Prognosis and outcome in patients with chronic inflammatory demyelinating polyradiculoneuropathy in a tertiary center in Oman
• Prospect of novel therapies in immune-mediated neuropathies
• Prospective open-label trial with rituximab in patients with chronic inflammatory demyelinating polyradiculoneuropathy not responding to conventional immune therapies
• Qualitative interviews to support development of a patient-reported companion measure to the glucocorticoid toxicity index
• Quantitative magnetic resonance neurography in chronic inflammatory demyelinating polyradiculoneuropathy: A longitudinal study over 6 years
• Rate and characteristics of inflammatory neuropathies associated with brentuximab vedotin therapy
• Recurrent CNTN1 antibody-positive nodopathy: a case report and literature review
• Rehabilitation of Rare Neurological Complications of COVID-19 Infection in Health Resort Settings
• Reply to the Letter to the Editor "Do corticosteroids aggravate pure motor chronic inflammatory demyelinating polyradiculoneuropathy (CIDP)?" by Kokubun N. et al
• Reply to the Letter to the Editor "Do corticosteroids aggravate pure motor chronic inflammatory demyelinating polyradiculoneuropathy (CIDP)?" by Kokubun N. et al. (in press, JPNS 2024)
• Sensory ataxic polyneuropathy unmasking late-onset urea cycle defect
• Sensory Chronic Inflammatory Demyelinating Polyradiculoneuropathy: Neglected Immunotherapy-Responsive Sensory Neuropathy
• Serological indication of chronic inflammatory demyelinating polyneuropathy as an extrahepatic manifestation of hepatitis E virus infection
• Serum Neurofilament and Free Light Chain Levels in Patients Undergoing Treatment for Chronic Inflammatory Demyelinating Polyneuropathy
• Successful autologous hematopoietic stem cell transplantation in a refractory anti-Caspr1 antibody nodopathy
• Successful treatment of relapsed and refractory CIDP with ofatumumab: a first case report
• Synergistic effects of immune checkpoints and checkpoint inhibitors in inflammatory neuropathies: Implications and mechanisms
• Tacrolimus-Induced Neurotoxicity After Transplant: A Literature Review
• The challenge of detecting monoclonal protein in POEMS syndrome: two case reports
• The multiple roles of nerve biopsy in the diagnosis and prognosis of suspected immune neuropathies
• The significance of autoantibodies against nodal and paranodal proteins in autoimmune nodopathies
• Typical CIDP, distal variant CIDP, and anti-MAG antibody neuropathy: An ultra-high frequency ultrasound comparison of nerve structure
• Typical CIDP: Update of the Pathogenesis, Diagnosis, and Treatment
• Upper and lower limb tremor in inflammatory neuropathies
• Usefulness of somatosensory evoked potentials for monitoring the clinical course of patients with chronic inflammatory demyelinating polyradiculoneuropathy
• Validation of elevated levels of interleukin-8 in the cerebrospinal fluid, and discovery of new biomarkers in patients with GBS and CIDP using a proximity extension assay